On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Ellen Warner

ResearcherPublications, citations & collaboration network

Ellen Warner is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Ellen Warner have?

ScholarIQindexed works

Ellen Warner has 360 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Ellen Warner have?

ScholarIQcitation count

Ellen Warner has 18,676 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Ellen Warner?

ScholarIQh-index

Ellen Warner has an h-index of 54 in OpenAlex.

What is the i10-index of Ellen Warner?

ScholarIQi10-index

Ellen Warner has an i10-index of 155 in OpenAlex.

What is the ORCID of Ellen Warner?

ScholarIQorcid

The ORCID for Ellen Warner is on the source record.

What is the OpenAlex record for Ellen Warner?

ScholarIQopenalex

The OpenAlex for Ellen Warner is on the source record.

What are the most-cited papers on Ellen Warner?

ScholarIQmost cited works
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Carolyn D. Runowicz, Corinne R. Leach, N. Lynn Henry, Karen S. Henry, Heather Mackey, Rebecca Cowens-Alvarado, Rachel Cannady, Mandi L. Pratt‐Chapman, Stephen B. Edge, Linda A. Jacobs, Arti Hurria, Lawrence B. Marks, Samuel J. LaMonte, Ellen Warner, Gary H. Lyman, Patricia A. Ganz
Journal of Clinical Oncology. 20151,043 Citations
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Carolyn D. Runowicz, Corinne R. Leach, N. Lynn Henry, Karen S. Henry, Heather Mackey, Rebecca Cowens-Alvarado, Rachel Cannady, Mandi L. Pratt‐Chapman, Stephen B. Edge, Linda A. Jacobs, Arti Hurria, Lawrence B. Marks, Samuel J. LaMonte, Ellen Warner, Gary H. Lyman, Patricia A. Ganz
CA A Cancer Journal for Clinicians. 2015746 CitationsOPEN ACCESS
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
David Miles, Joseph Gligorov, Fabrice André, David Cameron, Andreas Schneeweiß, Carlos H. Barrios, Binghe Xu, Andrew Wardley, Diego Kaen, Livia Andrade, Semiglazov Vf, Mattea Reinisch, Shilpen Patel, Monika Patre, L. Morales, Sipahee Lal Patel, Manika Kaul, Teresa Barata, Joyce O’Shaughnessy, Q. Zhang, Binghe Xu, Zhimin Shao, Xiangyu Wang, Cuizhi Geng, Xingchen Yan, Zhongsheng Tong, Kunwei Shen, Yongmei Yin, Tao Sun, James Chih‐Hsin Yang, J Feng, Min Yan, Yan Wang, Qiang Liu, S. Zhang, Michelino De Laurentiis, Armando Santoro, Valentina Guarneri, Marco Colleoni, Clara Natoli, Laura Cortesi, Sabino De Placido, Lorenzo Gianni, Francesco Ferraù, Lorenzo Livi, Alberto Zambelli, Lucia Del Mastro, Giuseppe Tonini, Filippo Montemurro, Giulia Bianchi, R. Pedersini, Salvatore A. Del Prete, Giacomo Allegrini, Giuseppe Naso, Patrizia Vici, D. Loirat, Audrey Mailliez, Franck Priou, Olivier Trédan, F. Dalenc, Christophe Perrin, Joseph Gligorov, Morales-Pancorbo David, Nadine Dohollou, Luís Teixeira, Fabien Brocard, Antoine Arnaud, Suzette Delaloge, Jean‐Philippe Spano, Luigi Mansi, Livia Andrade, Fernanda Damian, José Luiz Pedrini, Sandra M. Aleixo, Roberto Hegg, R. Junior, Mattea Reinisch, Marcus Schmidt, C. Wenzel, E.‐M. Grischke, Andreas Schneeweiß, Marianne Just, Nadia Harbeck, Claudia Schumacher, Ubong Peters, Dorothea Fischer, Helmut Forstbauer, Rüdiger Liersch, Ellen Warner, Nathaniel Bouganim, C. T. Doyle, Julie Price Hiller, Ted Vandenberg, Michel Pavic, Andrew Robinson, Gloria Roldan Urgoiti, Nadia Califaretti, Ahmet Alacacıoğlu, M. Gumus, Bülent Yalçın
Annals of Oncology. 2021741 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account